Ruiz-Fernández Carmen, Cuesta Ricardo, Martín-López Susana, Guijarro Javier, López Gómez de Las Huertas Arturo, Urroz Mikel, Miguel-Berenguel Laura, González-Muñoz Miguel, Ramírez Elena
Immunology Department, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
Clinical Pharmacology Department, La Paz University Hospital-IdiPAZ, Faculty of Medicine, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
Pharmaceuticals (Basel). 2023 May 9;16(5):720. doi: 10.3390/ph16050720.
Severe acute respiratory syndrome coronavirus 2 caused the global COVID-19 pandemic and public health crisis, and it led to the rapid development of COVID-19 vaccines, which can cause rare and typically mild hypersensitivity reactions (HRs). Delayed HRs to COVID-19 vaccines have been reported, and the excipients polyethylene glycol (PEG)2000 and polysorbate 80 (P80) are the suspected culprits. Skin patch tests do not help in diagnosing delayed reactions. We aimed to perform lymphocyte transformation tests (LTT) with PEG2000 and P80 in 23 patients with suspected delayed HRs. Neurological reactions (n = 10) and myopericarditis reactions (n = 6) were the most frequent complications. Seventy-eight percent (18/23) of the study patients were admitted to a hospital ward, and the median time to discharge was 5.5 (IQR, 3-8) days. Some 73.9% of the patients returned to baseline condition after 25 (IQR, 3-80) days. LTT was positive in 8/23 patients (5/10 neurological reactions, 2/4 hepatitis reactions and 1/2 rheumatologic reactions). All myopericarditis cases had a negative LTT. These preliminary results indicate that LTT with PEGs and polysorbates is a useful tool for identifying excipients as causal agents in HRs to COVID-19 vaccines and can play an important role in risk stratification in patients with HRs.
严重急性呼吸综合征冠状病毒2引发了全球新冠疫情和公共卫生危机,这促使新冠疫苗迅速研发出来,而这些疫苗可能会引发罕见且通常较为轻微的超敏反应(HRs)。已有关于新冠疫苗延迟性超敏反应的报道,辅料聚乙二醇(PEG)2000和聚山梨酯80(P80)被怀疑是罪魁祸首。皮肤斑贴试验无助于诊断延迟反应。我们旨在对23例疑似延迟性超敏反应患者进行PEG2000和P80的淋巴细胞转化试验(LTT)。神经反应(n = 10)和心肌心包炎反应(n = 6)是最常见的并发症。78%(18/23)的研究患者被收治入院,出院中位时间为5.5(四分位间距,3 - 8)天。约73.9%的患者在25(四分位间距,3 - 80)天后恢复到基线状态。23例患者中有8例(5/10例神经反应、2/4例肝炎反应和1/2例风湿反应)LTT呈阳性。所有心肌心包炎病例的LTT均为阴性。这些初步结果表明,用聚乙二醇和聚山梨酯进行淋巴细胞转化试验是一种有用的工具,可用于确定辅料是新冠疫苗超敏反应的致病因素,并可在超敏反应患者的风险分层中发挥重要作用。